Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Psyence Australia Pty Ltd
Daiichi Sankyo
ImmunityBio, Inc.
University of Pittsburgh
Rain Oncology Inc
Convalife (Shanghai) Co., Ltd.
MultiVir, Inc.
Delcath Systems Inc.
National Cancer Institute (NCI)